Journal
NEUROLOGICAL SCIENCES
Volume 43, Issue 2, Pages 785-788Publisher
SPRINGER-VERLAG ITALIA SRL
DOI: 10.1007/s10072-021-05752-8
Keywords
SARS-CoV-2; COVID-19; Memory; Cognitive assessment; Attention
Categories
Ask authors/readers for more resources
Episodic long-term memory deficits are common in COVID-19-recovered patients, with both primary and secondary etiology possibly playing a role. Screening for these deficits is important, especially in patients with moderate-to-severe COVID-19 and those already at risk for cognitive decline. Different measures of verbal LTM can be used, with the I-level measures potentially being more sensitive.
Background Episodic long-term memory (LTM) difficulties/deficits are frequent in COVID-19-recovered patients and negatively impact on prognosis and outcome. However, little is known about their semiology and prevalence, also being still debated whether they arise from primary amnesic features or are secondary to dysexecutive/inattentive processes and disease-related/premorbid status. Hence, this study aimed at (1) assessing LTM functioning in post-infectious SARS-CoV-2 patients by accounting for premorbid and disease-related confounders and (2) exploring its cognitive etiology. Methods Measures of global cognition (Mini-Mental State Examination (MMSE) and Montreal Cognitive Assessment (MoCA)) and LTM (Babcock Memory Test (BMT)) of fifty-four COVID-19-recovered patients were retrospectively collected. Patients were subdivided into those being already at risk or not for cognitive decline (RCD + ; RCD -). Cognitive measures were converted into equivalent scores (ESs). Results LTM sub-clinical/clinical deficits (ESs = 0/1) were mildly-to-moderately prevalent in both RCD + (MoCA-Memory, 31.8%; BMT, 31.8%) and RCD - (MoCA-Memory, 28.6%; BMT, 39.3%) patients. MMSE and MoCA total scores, but not the MoCA-Attention subtest, were associated with the BMT. RCD + asymptomatic patients performed better on the BMT (p = .033) than those requiring O-2 therapy (but not ventilation). Discussion COVID-19-recovered individuals might show LTM deficits of both primary and secondary etiology and should be thus screened for them, especially those having suffered mid-to-moderate COVID-19 and those already being at risk for cognitive decline. Both I- and II-level measures of verbal LTM can be adopted, although the former might be more sensitive.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available